Guoliang Shao - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Guoliang Shao

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Liver Cancer|August 11, 2022

Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert StatementsYongkun Sun, Wen Zhang, Xinyu Bi, et al.

Hepatobiliary Surgery and Nutrition|April 25, 2022

Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)Hui-Chuan Sun, Jian Zhou, Zheng Wang, et al.

JHEP Reports : Innovation in Hepatology|January 6, 2025

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>Dongdong Xia, Wei Bai, Qiuhe Wang, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Liver Cancer|August 11, 2022

Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert StatementsYongkun Sun, Wen Zhang, Xinyu Bi, et al.

Hepatobiliary Surgery and Nutrition|April 25, 2022

Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)Hui-Chuan Sun, Jian Zhou, Zheng Wang, et al.

JHEP Reports : Innovation in Hepatology|January 6, 2025

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>Dongdong Xia, Wei Bai, Qiuhe Wang, et al.

Pageof 9